Conference News

  • Think about breast cancer surveillance for transgender patients

    on March 30th, 2018
    REPORTING FROM ENDO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Both transgender men and transgender women had an increased risk of breast cancer compared with a male, but not a female, reference population, said Christel de Blok, MD, sharing results of a Dutch national study. The study included 3,078[...]
  • Checkpoint inhibition less toxic than antiangiogenic therapy in NSCLC

    on March 30th, 2018
    REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – Checkpoint blockade is associated with reduced toxicity when compared with antiangiogenic therapies for the treatment of advanced non–small-cell lung cancer, a systematic review and meta-analysis suggests. In 16,810 pat[...]
  • Robocalls increase diabetic retinopathy screenings in low-income patients

    on March 29th, 2018
    REPORTING FROM ENDO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Sending robocall reminders increased diabetic retinopathy screenings significantly among low-income, minority patients, according to a presentation at the annual meeting of the Endocrine Society. Patients with diabetes require routine dia[...]
  • Declining androgen levels correlated with increased frailty

    on March 27th, 2018
    REPORTING FROM ENDO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Declining androgen levels are associated with deteriorating physical function and increased frailty in aging men, according to a study presented at the annual meeting of the Endocrine Society. The findings provide more evidence of the rel[...]
  • HDAC inhibition may boost immune therapy efficacy in breast cancer

    on March 27th, 2018
    REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – The novel combination of entinostat and nivolumab with or without ipilimumab showed encouraging safety, tolerability, and antitumor activity in early results from an ongoing phase 1 trial of patients with advanced breast [...]
  • Oral SGLT-2 inhibitor reduced liver fat in diabetics with NAFLD

    on March 27th, 2018
    REPORTING FROM ENDO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Empagliflozin, an oral sodium-glucose cotransporter 2 (SGLT-2), reduced liver fat by 5% and improved ALT in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus, according to a study presented at the annual [...]
  • Over one-third report financial burden from breast cancer treatment

    on March 27th, 2018
    REPORTING FROM SSO 2018 CHICAGO (FRONTLINE MEDICAL NEWS) – Women who have treatment for breast cancer seldom talk about the costs of care with their medical team, but a study out of Duke University has found that more than one-third reported having a financial burden from their breast cancer treat[...]
  • Opinions clash over private equity’s effect on dermatology

    on March 27th, 2018
    EXPERT ANALYSIS FROM AAD 18 SAN DIEGO – Although the intrusion of private equity in the ownership and operation of U.S. dermatology practices that has been snowballing for a little under a decade is often bemoaned by dermatologists, at least some physicians in the field see it as a positive develo[...]
  • Sling revisions: pain as indication linked with SUI recurrence

    on March 27th, 2018
    REPORTING FROM SGS 2018 ORLANDO (FRONTLINE MEDICAL NEWS) – Pain as an indication for midurethral sling revision is associated with an elevated risk of postoperative stress urinary incontinence recurrence, according to a review of 129 cases. At a mean follow-up of 21 months, the overall rate of rec[...]
  • Switching to tenofovir alafenamide may benefit HBV patients

    on March 26th, 2018
    EXPERT ANALYSIS FROM DIGESTIVE DISEASES: NEW ADVANCES PHILADELPHIA (FRONTLINE MEDICAL NEWS) – Tenofovir alafenamide, the newest kid on the block for treatment of chronic hepatitis B, not only has less bone and renal effects than tenofovir disoproxil, but now also appears to improve those parameter[...]
  • Major message: Most heart failure is preventable

    on March 26th, 2018
    EXPERT ANALYSIS FROM THE ANNUAL CARDIOVASCULAR CONFERENCE AT SNOWMASS SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – More than 960,000 new cases of heart failure will occur in the United States this year – and most of them could have been prevented, Gregg C. Fonarow, MD, asserted at the Annual Cardi[...]
  • CBC data can predict immunotherapy responses in NSCLC

    on March 25th, 2018
    REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – Information readily available on complete blood count can help predict response to immunotherapy and outcomes in patients with advanced non–small cell lung cancer, according to findings from a review of 157 cases. Speci[...]
  • Top hospital heart failure performance translates to longer survival

    on March 24th, 2018
    REPORTING FROM ACC 2018 ORLANDO (FRONTLINE MEDICAL NEWS) – Hospitals in the first quartile of short-term performance in treating heart failure patients had higher long-term survival rates for those patients, based on data from 317 hospitals that participated in a voluntary quality improvement prog[...]
Back to top